REFERENCES
- Brenner, P. F., Guerrero, R., Cekan, Z. & Diczfalusy, E. 1973. Radioimmunoassay method for six steroids in human plasma. Steroids 22, 775.
- Forsgren, B., Gustafsson, J.-Å., Pousette, Å. & Högberg, B. 1980. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramusine, a nitrogen mustard derivative of oestradiol-17β. Cancer Res, in press.
- Fosså, S. D., Fosså, J. & Aakwaag, A. 1977. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. J Urol 118, 1013.
- Franzén, S., Giertz, G. & Zajicek, J. 1960. Cytological diagnosis of prostatic tumours of transrectal aspiration biopsy: A preliminary report. Br J Urol 32, 193.
- Harper, M. E., Peeling, W. B., Cowley, T., Brownsey, B. G., Phillips, M. E. A., Groom, G., Fahmy, D. R. & Griffiths, K. 1976. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol 81, 409.
- Högberg, B., Björk, P., Carlström, R., Forsgren, B., Gustafsson, J.-Å., Hökfelt, T. & Pousette, Å. 1980. The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate. In: Prostate cancer and hormone receptors. Alan Liss Inc., New York, in press.
- Jönsson, H., Högberg, B. & Nilsson, T. 1977. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt®). Scand J Urol Nephrol 11, 231.
- Jönsson, G., Olsson, A. M., Luttrop, W., Cekan, Z., Purvis, K. & Diczfalusy, E. 1975. Treatment of prostatic carcinoma with various types of estrogen derivatives. In Vitamins and hormones, Vol. 33, International Symposium on Endocrine Control of the Prostate, pp. 351–376. Academic Press, New York.
- Kadohama, N., Kirdani, R. Y., Murphy, G. P. & Sandberg, A. A. 1978. Estramustine phosphate: Metabolic aspects related to its action in prostatic cancer. J Urol 119, 235.
- Larsson, L. G. & Sundbom, C. M. 1962. Roentgen irradiation of the male breast. Acta Radiol (Stockholm) 58, 253.
- Müntzing, J., Jensen, G. & Högberg, B. 1979. Pilot study on the growth inhibition by estramustine phosphate (Estracyt®) of rat mammary tumours sensitive and insensitive to oestrogen. Acta Pharmacol toxicol 44, 1.
- Müntzing, J., Kirdani, R. Y., Saroff, J., Murphy, G. P. & Sandberg, A. 1977. Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma. Urology 10, 439.
- Müntzing, J., Shukla, S. K., Chu, T. M., Mittelman, A. & Murphy, G. P. 1974. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. Invest Urol 12, 65.
- Musa, B. U., Seal, U. S. & Doe, R. P. 1965. Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship. J Clin Endocrinol Metab 25, 1163.
- Robertson, D. M. & Diczfalusy, E. 1977. Biological and immunological characterization of human luteinizing hormone. II. A comparison of the immunological and biological activities of pituitary extracts after electrofusing using different standard preparations. Molecul Cellul Endocrinol 9, 57.
- Robinson, M. R. & Thomas, B. S. 1971. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Br Med J 4, 391.
- Ruder, H. J., Guy, R. L. & Lipsett, M. B. 1972. A radioimmunoassay for cortisol in plasma and urine. J Clin Endocrinol 35, 219.
- Sandberg, A. A. & Slaunwhite, W. R., Jr. 1959. Transcortin: a corticosteroid binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J Clin Invest 38, 1290.
- Sjöberg, B., de la Torre, Hedman. M., Falkay, G. & Diczfalusy, E. 1979. Circadian variation in systemic hormone levels in healthy men. J Endocrinol Invest 2, 131.
- Thorell, J. I. & Johansson, B. G. 1971. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 251, 363.
- Veterans Administration Cooperative Urological Research Group. 1967. Treatment and survival of patients with cancer of the prostate. Surg Gynec Obstet 124, 1011.